Cardiology

After showing a significant impact on reduction of cardiovascular events, a slew of subgroup analyses were performed examining use of icosapent ethyl using data derived from REDUCE-IT.

The investigative monoclonal antibody from Regeneron shows significant benefit for patients with the rare, severe homozygous familial hypercholesterolemia.

Trial investigator Deepak Bhatt, MD, MPH, discusses how use of rivaroxaban in a clinical setting has changed as a result of the COMPASS trial.

Lead investigator of REDUCE-IT trials discusses the impact of trial results and what that means for EPA-based treatments going forward.

Use of rivaroxaban (Xarelto) plus aspirin was found to reduce cardiovascular and major limb events in a secondary analysis of the COMPASS trial.

How do the states with the longest-running legislation permitting MAID compare?

The committee meeting, tentatively scheduled for November 14, will have to precede the sNDA PDUFA action date set to review the drug's potential indication for reducing residual cardiovascular risks in patients with elevated triglycerides.

Stimulating the sphenopalatine ganglion-a collection of nerve cells closely associated with the trigeminal nerve most responsible for headaches-could be a safe intervention for patients with acute ischemic stroke who aren’t eligible for thrombolytic therapy, according to an article published in The Lancet last month.

A 34-year-old male with no significant past medical history presents to the emergency department with 10 hours of constant chest pain radiating into his back that started last night. What's your diagnosis?

A 22-year-old male with no significant past medical history is brought to the emergency department for syncope. He was getting a haircut when he fainted. What's your diagnosis?

Strict adherence to a plant-based diet could result in a 16% reduction in risk of having a cardiovascular disease.

An 83-year-old woman with kidney disease was brought to the ED for heart palpitations and shortness of breath. What's your diagnosis?

Perioperative management of patients with atrial fibrillation receiving a direct oral anticoagulant associated with low rates of major bleeding and arterial thromboembolism in the PAUSE study.

Obesity, smoking, and other trends are slowing the rate of decline, and even causing increases, of cardiovascular disease in many high-income countries across the world.

Proof-of-concept study follows patients who receive a HCV-positive donor heart.

Deepak Bhatt, MD, discusses the results of the COMPASS trial and how they have impacted clinical practice.

A new international cohort shows hospitals with a greater annual volume of PE patients often report better patient outcomes.

Investigators examining more than 1000 university students found that those using a smartphone more than 5 hours per day had a 43% increased risk of obesity.

Investigators from Brigham and Women's Hospital found no difference in mortality rate among procedures, even those that coincide with the start of resident training.

With approval, Baqsimi, which was approved for adults and children as young as 4, becomes the first approved treatment of hypoglycemia that can be administered without an injection.

In a recent study, investigators from Johns Hopkins found that risks of peripheral artery disease remains elevated for 30 years after smoking cessation.

Results of the SHINE trial show no significant difference between standard and intensive treatment of hyperglycemia on functional outcomes following acute ischemic stroke.

A recent study has found that the cost and accessibility of PCSK9 inhibitors has created problems for patients seeking an effective treatment for their hypercholesterolemia.

Investigators from the University of Duke School of Medicine compared results of the PROSPER Study and found results supporting the use of DOACs over warfarin in older patients following ischemic stroke.

From vaping to air pollution, Deepak Bhatt, MD, shares his thoughts on the greatest threats to cardiovascular health.

A recent study of more than 12 million people from 10 countries found that the risk of heart failure associated with diabetes was greater in women than in men. 



Deepak Bhatt, MD, executive director of Interventional Cardiovascular Programs at Brigham and Women's Hospital and professor of medicine at Harvard Medical School, discusses potential forthcoming advances in cardiology that excite him most.

A new study links high levels of high‐sensitivity cardiac troponin T and N‐terminal pro‐B‐type natriuretic peptide to an increase in fall risk for geriatric adults.